Kapynag Pharma Private Limited, a active private limited company, was established on 08 September 2017 in Nashik, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909MH2017PTC299496. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 15 professional, Its leadership includes Gangadhar Ramchandra Kakulate (Director), Lalit Dnyandeo Dhondge (Director), Ashwini Girish Dhondge (Director). Past directors included Sandip Jagannath Patil, Bhavana Kunal Wagh, Surekha Avinash Kamodkar. It holds ₹6.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at M/S Agri Search India Pvt. Ltd., Unit-2 G. No. 211, At Pimpalnare, Tal Dindori, Nashik, Maharashtra, 422202.
U51909MH2017PTC299496
299496
08 September 2017
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kapynag Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gangadhar Ramchandra Kakulate | Director | 25 Jun 2022 | Current |
| Lalit Dnyandeo Dhondge | Director | 21 Jan 2022 | Current |
| Ashwini Girish Dhondge | Director | 05 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Feb 2021 | Past |
| Pramod Abcsdd | Director | 27 Feb 2021 | Past |
| Pramod Abcsdd | Director | 27 Feb 2021 | Past |
| Pramod Abcsdd | Director | 27 Feb 2021 | Past |
| Pramod Abcsdd | Director | 26 Jun 2018 | Past |
| Pramod Abcsdd | Director | 26 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kapynag Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 689.55% increase. The company also saw a substantial improvement in profitability, with a 681.89% increase in profit. The company's net worth Soared by an impressive increase of 242.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Kapynag Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2022 | Hdfc Bank Limited | ₹6.00 M | Open |
Explore comprehensive loan charge details -
Kapynag Pharma has a workforce of 15 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kapynag Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kapynag Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kapynag Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Kapynag Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge with Hdfc Bank Limited of Rs. 6.00 M registered on 23 Mar 2022 with Charge ID 100559718 was modified on 08 Aug 2023. was completed.
The activity Gangadhar Ramchandra Kakulate was appointed as a Director was appointed as a Director on 25 Jun 2022 & has been associated with this company since 3 years 5 months . was completed.
A charge with Hdfc Bank Limited amounted to Rs. 6.00 M with Charge ID 100559718 was registered on 23 Mar 2022. was recorded as a recent event.
The activity Lalit Dnyandeo Dhondge was appointed as a Director was appointed as a Director on 21 Jan 2022 & has been associated with this company since 3 years 10 months . was completed.
The CIN of Kapynag Pharma Private Limited is U51909MH2017PTC299496.
Kapynag Pharma Private Limited is headquartered at M/S Agri Search India Pvt. Ltd., Unit-2 G. No. 211, At Pimpalnare, Tal Dindori, Nashik, Maharashtra, 422202.
Kapynag Pharma Private Limited was incorporated on 08 September 2017.
The current directors of Kapynag Pharma Private Limited are
The primary industry of Kapynag Pharma Private Limited is Trade.
Kapynag Pharma Private Limited is unlisted.
The authorized capital of Kapynag Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Kapynag Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX